Vilario-Gell, C
Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J et al (2025) Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
This supports the mitochondria during the high-demand healing phase [1, 3]
With the last expiring follow-on patent being in 2042, this amounts to a period of 49 years of patent protection in total
Thrive+ Shot B12, B5, B6 L-Carnitine, L-Arginine Methionine, Inositol, Choline Package: $250 for 10 shots + free Styku body composition scan
PubMed PMID: 22074294